PER 1.23% 8.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-11

  1. 4,149 Posts.
    You and all other shareholders just got raped.
    History repeats itself.... Diamond stays in power with a new friend who has walked away with 20% of the company .
    Poor old Leon who blew 750k at the last cr at 11c must have egg on face to see his investment blown apart.
    My opinion is that it's an absolute insult to all shareholders to be diluted so cheaply after suggesting licensing deals, Eap revenues, non dilutive funding and promising change at the last 2 agms.
    What a load of rubbish and there is no way on earth I would invest 1 cent in this capital destroying company.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $81.90M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $133.2K 1.679M

Buyers (Bids)

No. Vol. Price($)
7 575000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 442878 5
View Market Depth
Last trade - 11.43am 01/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.